- Filed
- Mar 27, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 25, 2026 | 31.21M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 31.11M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 31.07M sh |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | $2.89M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | $282.83K |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $12.9M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $4.59M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $29.78M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $30.05M |
| Stockholders Equity restated | FY 2025 · Dec 31, 2023 | $27.72M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $14.35M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $16.6M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $14.35M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $17.12M |
| Current Assets | FY 2025 · Dec 31, 2025 | $42.56M |
| Current Assets | FY 2025 · Dec 31, 2024 | $44.46M |
| Total Assets | FY 2025 · Dec 31, 2025 | $44.13M |
| Total Assets | FY 2025 · Dec 31, 2024 | $47.17M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.09 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$0.12 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$0.09 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$0.12 |
| Rd Expense | FY 2025 · Dec 31, 2025 | $2.92M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $1.44M |
| Net Income | FY 2025 · Dec 31, 2025 | −$2.87M |
| Net Income | FY 2025 · Dec 31, 2024 | −$3.77M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$3.76M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$6.99M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $14.16M |
| Cost Of Revenue | FY 2025 · Dec 31, 2024 | $7.33M |
| Revenue | FY 2025 · Dec 31, 2025 | $30.26M |
| Revenue | FY 2025 · Dec 31, 2024 | $20.15M |